Latest News

To reach our marketing department, you can email them directly at marketing@pawprintgenetics.com.

NEOGEN’s Genetic Veterinary Sciences, Inc. Facility Earns ISO 17025 Accreditation

Prestigious accreditation demonstrates company’s commitment to quality, competency, and reliability

LINCOLN, Neb., April 5, 2022 — NEOGEN Corporation (NASDAQ: NEOG) announced today that its Genetic Veterinary Sciences, Inc. (GVS) facility has received ISO/IEC 17025:2017 accreditation from the American Association for Laboratory Accreditation (A2LA) — the highest recognized quality standard in the world for testing and calibration laboratories.

ISO/IEC 17025 is one of the most important internationally recognized quality standards and was developed to promote confidence in testing and calibration labs by setting requirements to demonstrate competency and ability to generate valid results.

Receiving the accreditation means that test reports and certificates generated by the Spokane, Washington-based laboratory can now be generally accepted from one country to another without further testing.

“We are incredibly proud to receive this important accreditation, demonstrating our commitment to quality, competency, and reliability in our laboratory personnel and processes,” said Marylinn Munson, Vice President of Genomics at NEOGEN. “This accreditation exemplifies our discipline to upholding rigorous quality management systems. Veterinarians, breeders, and owners of companion animals around the world can be reassured that GVS tests are accurate, precise, and produce valid test results.”

ISO (the International Organization for Standardization) is an international standard-setting body composed of representatives from 167 national standards organizations. ISO promulgates world-class specifications standards ensure quality, safety, and efficiency for almost every industry from technology to food safety, agriculture, and healthcare.

About NEOGEN

NEOGEN Corporation develops and markets comprehensive solutions dedicated to food and animal safety. The company’s Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. NEOGEN’s Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.

###

NEOGEN Acquires Genetic Veterinary Sciences, Inc. (DBA Paw Print Genetics)

NEOGEN Acquires Genetic Veterinary Sciences, Inc.
(DBA Paw Print Genetics)

LINCOLN, Neb., December 9, 2021 — NEOGEN Corporation (NASDAQ: NEOG) announced today that it has acquired Spokane, Washington-based companion animal genetic testing company Genetic Veterinary Sciences, Inc.

Genetic Veterinary Sciences, Inc. (“GVS”) was founded in 2012 and is dedicated to providing companion animal owners, breeders, and veterinarians genetic information that enables optimal genetic health for dogs, cats, and birds. Their brands include Paw Print Genetics, Canine HealthCheck, My CatScan, and AvianDx.

 “We are happy to have GVS join the NEOGEN team,” said Marylinn Munson, NEOGEN’s Vice President of Genomics. “With the growth in pet parenting globally over the past five years, and particularly as a result of the COVID-19 pandemic, this acquisition will further expand the opportunities for our global genomics business. As a global leader in animal genomic testing, it is important for NEOGEN to continue expanding our portfolio of genomic tests and diversify our offerings in agriculture and food production to include enhanced testing for companion animals. The NEOGEN and GVS teams will be able to combine our experiences and expertise to work synergistically, as we help meet the demands of the growing market.”

“Joining NEOGEN is a wonderful opportunity for Paw Print Genetics and our related brands,” said Lisa Shaffer, founder and Chief Executive Officer of GVS. “I am incredibly proud of everything that we have accomplished since 2012 and am looking forward to GVS becoming a part of NEOGEN, a world leader in high throughput genomic testing for animals. The focus on quality and accuracy, which has been a hallmark of GVS, coupled with the global reach and expertise from NEOGEN, will continue to grow the companion animal market and deliver solutions focused on the health and wellbeing of pets and the human-animal bond.”

Terms of the agreement were not disclosed.

NEOGEN Corporation develops and markets comprehensive solutions dedicated to food and animal safety. The company’s Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. NEOGEN’s Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.

For the 2nd Time, Genetic Veterinary Sciences, Inc. Appears on the Inc. 5000, Ranking No. 3511 With Three-Year Revenue Growth of 97 Percent

For the 2nd Time, Genetic Veterinary Sciences, Inc. Appears on the Inc. 5000,  Ranking No. 3511 With Three-Year Revenue Growth of 97 Percent

Inc. magazine today revealed that Genetic Veterinary Sciences, Inc. is No. 3511 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. This is the second year in a row that Genetic Veterinary Sciences, Inc. has made the list.

 

“Not only are we excited to be named to the Inc. 5000 for a second, consecutive year” states Lisa G. Shaffer, PhD, Founder and CEO of Genetic Veterinary Sciences, Inc., “our ranking improved by more than 450 points. This is a testament to the hard work and dedication of our staff and to the loyalty of our customers over this past, very challenging year.”

 

Not only have the companies on the 2021 Inc. 5000 been very competitive within their markets, but this year’s list also proved especially resilient and flexible given 2020’s unprecedented challenges. Among the 5,000, the average median three-year growth rate soared to 543 percent, and median revenue reached $11.1 million. Together, those companies added more than 610,000 jobs over the past three years.

 

“The 2021 Inc. 5000 list feels like one of the most important rosters of companies ever compiled,” says Scott Omelianuk, editor-in-chief of Inc. “Building one of the fastest-growing companies in America in any year is a remarkable achievement. Building one in the crisis we’ve lived through is just plain amazing. This kind of accomplishment comes with hard work, smart pivots, great leadership, and the help of a whole lot of people.”

 

About Genetic Veterinary Sciences, Inc.

Located in Spokane, Washington, Genetics Veterinary Sciences, Inc. was founded in 2012. Genetic Veterinary Sciences, Inc. is dedicated to achieving optimal genetic health for your companion animals by providing outstanding resources for dog, cat and bird owners, breeders, and veterinarians. More information about their products can be found at www.pawprintgenetics.comwww.caninehealthcheck.comwww.mycatscan.com and www.aviandx.com.

 

For more information regarding this topic, please contact Jessica Pieros at jpieros@pawprintgenetics.com or 509-572-8507

 

 

More about Inc. and the Inc. 5000

 

Methodology

Companies on the 2021 Inc. 5000 are ranked according to percentage revenue growth from 2017 to 2020. To qualify, companies must have been founded and generating revenue by March 31, 2017. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2020. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2017 is $100,000; the minimum for 2020 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Growth rates used to determine company rankings were calculated to three decimal places. There was one tie on this year’s Inc. 5000.  Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

 

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including web sites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Vision Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com.

For more information on the Inc. 5000 Vision Conference, visit http://conference.inc.com/.

 

###